Maintenance therapy in hormone receptor-positive and human epidermal growth factor receptor 2-positive metastatic breast cancer: a real-world multicenter retrospective study
Maintenance therapy using trastuzumab combined with endocrine therapy following standard first-line treatment may improve the survival and safety of patients with HR+/HER2+ MBC.
Authors
- Yongmei Yin
- Shengnan Bao
- Jia Xu Chen
Institutions
- Nantong Tumor Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fonc.2025.1703657
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- Nantong University